Metropolis Healthcare Limited
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.
What Metropolis files
- Others61
- Investor Meet54
- Important33
- Updates23
- PPTs10
- Board Meeting9
Metropolis Healthcare has allotted 66,312 equity shares at INR 2 each under its employee stock unit plan, raising the total issued share capital to INR 41.49 crore. Half of these newly issued shares carry a one-year lock-in period.
Metropolis Healthcare’s subsidiary, MQSPL, has entered into subscription and shareholder agreements to restructure and scale its external quality assessment services business. Following incoming investments and phased conversions, MHL will hold a 54.90% stake, consolidating its operational leadership and R&D capabilities.
Metropolis Healthcare transferred its EQAS Division to its subsidiary, MQSPL, for INR 1.25 Cr. The consideration was paid through MQSPL equity shares. MQSPL will now manage all EQAS operations.
Metropolis Healthcare delivered strong Q1FY27 results: Revenue up 17% to ₹450 Cr, EBITDA up 27% to ₹113 Cr, and PAT up 26% to ₹57 Cr. Robust patient/test volume growth (+10-11%) and 210 bps EBITDA margin expansion highlight quality performance across segments and geographies.
Metropolis Healthcare will hold its 26th Annual General Meeting (AGM) virtually. The Annual Report for FY25-26 is now accessible, allowing investors to review the past fiscal year's performance and company updates.